REG - Greencare Capital - Portfolio Company Voyager Life plc - IPO

LMS CapitalAnnouncement

30/06/2021 14:35

RNS Number : 6898D
  
Greencare Capital PLC
  
30 June 2021
  
 

 
Greencare Capital plc
("Greencare" or the "Company")
 
Portfolio Company achieves successful IPO and Admission to Aquis Stock Exchange
 
£100,000 Pre-IPO investment  in Voyager Life plc valued at £153,000 at Issue price 
of 58 pence per share
 
Greencare (AQSE: GRE), the investment company focused on investing in CBD and related wellness areas, is pleased to announce that the entire issued share capital of one of its portfolio companies, Voyager Life plc ("Voyager" - AQSE: VOY) the health and wellness business focussed on CBD and hemp seed oil, has today been admitted to trading on London's  AQUIS Growth Exchange.
 
In April this year, Greencare announced that it had made a £100,000 equity investment in Voyager; this holding now represents approximately 2.8% of Voyager's enlarged issued share capital on admission.
 
At the issue price of 58 pence per Ordinary share, Greencare's investment in Voyager is valued at approximately £153,000. 
 
The full text of the AQUIS Listing announcement from Voyager is available online at: 
https://www.aquis.eu/aquis-stock-exchange/for-investors/announcements?view_news_id=3147618
 
Richard Tonthat, Greencare CEO, commented:
"The CBD sector is poised for rapid growth, with the UK being one of the world's largest and fastest growing markets for CBD products. Voyager is looking to capitalise on the forecast growth and ongoing regulatory changes in the UK CBD market, which is forecast to surpass the value of the entire herbal supplements market and be worth more than £1bn by 2025. Voyager has already developed a range of life brands and skincare products which are now generating revenue through a number of distribution channels, including specialist retailers and mainstream online platforms.  
 
"We are delighted to witness today's successful listing and to have participated in the pre-IPO funding. We look forward to seeing more positive developments at Voyager. Voyager was the second investment made by Greencare since its own IPO on the Aquis Growth Exchange and the Company is currently assessing an exciting, ever increasing pipeline of other potential transactions."
 
 
Enquiries:
 



Greencare Capital plc
Richard Tonthat, CEO
 


+44 (0)20 7933 8780




Cairn Financial Advisers LLP
AQSE Corporate Adviser
Jo Turner / James Lewis
 


+44 (0)20 7213 0885
 
 
 
 




Walbrook PR Limited
Paul Vann/Nicholas Johnson
 


+44 (0)20 7933 8780
+44 (0)7768 807631



 
About Voyager Life plc:
Voyager, a health and wellness business focussed on CBD and hemp seed oil, has developed a range of products under the Voyager and Voyager Life brands, including oils, gummies, bath and skincare products and is already generating revenues.  It is currently developing a number of distribution channels which include direct sales, drop shipping, specialist retailers and online marketplaces. 
 
About Greencare Capital plc:
Greencare Capital plc is an investment company quoted on the Aquis Stock Exchange Growth Market. The Company was incorporated on 1 October 2019 and its shares were admitted to trading on 30 December 2019.
 
The Company's investment strategy is to focus on investments in cannabis sectors within countries predominantly in Europe whose jurisdictions have well-developed and reputable laws and regulations for its production, research and distribution; together with the CBD and hemp sectors. 
 
The Company will invest directly or indirectly in public or private companies, in supply and distribution chains, or other business associated with the cannabis sector. Investments may take the form of debt or equity and it is expected that such investments will ordinarily seek capital growth in the medium term in preference to income. 
 
The Company will not invest in the recreational cannabis sector, or in entities or activities supported by it, nor any other related activities which would be deemed illegal under UK legislation.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
NEXFMMTTMTTJBRB